CD44 and urinary bladder carcinoma: For example, Li et al. combined 2 monoclonal antibodies of human bladder cancer against BCMab1 and CD44 to isolate the BCMab1+CD44+ subgroup with strong proliferative and self-renewal properties that were associated with stem cells [35].